相关实验视频

Updated: Feb 24, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

与年龄相匹配的男性相比,在绝经后女性服用鱼油补充剂后,血n-3多不和脂肪酸的增加更高

David C R Ku¹, Insaf Loukil², Annick Vachon²

¹Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

|February 23, 2026

概括

鱼油补充剂在老年人中显著增加了欧米茄-3脂肪酸. 与男性相比,女性对血中脂酸eicosapentaenoic acid (EPA) 和docosahexaenoic acid (DHA) 的反应更大.

科学领域:

营养科学营养科学
生物化学生物化学
老年学是一门学科.

背景情况:

欧米茄-3 (n-3) 多不和脂肪酸 (PUFA),包括乙酸 (EPA) 和酸 (DHA),对健康至关重要.
在老年人中,n-3PUFA的代谢途径,特别是中间体,尚未完全理解.
以前的研究还没有完全描述鱼油补充剂对老年人群n-3PUFA代谢的影响.

研究的目的:

研究鱼油补充剂对老年人n-3PUFA水平的影响.
为了检查补充剂后EPA和DHA代谢中的潜在的性别依赖差异.
描述鱼油对特定n-3PUFA中间体的影响.

主要方法:

一项为期5个月的鱼油补充剂研究,涉及10名绝经后女性和10名年龄相匹配的男性.
通过鱼油补充剂每天摄入1.8g EPA和1.4g DHA.
在补充剂之前和之后分析血脂和三糖醇n-3PUFA水平.

主要成果:

显著的性别 × 补充相互作用效应观察到血脂EPA,DHA和24:5n-3.
与男性相比,女性在补充后的血脂EPA (69%),DHA (101%) 和24:5n-3 (182%) 的水平显着更高.
补充导致血三糖醇 (EPA,DHA,22:5n-3和24:5n-3) 在两性 (83%-327%) 中显著增加.

结论:

鱼油补充剂有效地增加了健康的老年人中的n-3PUFA水平.
在服用鱼油补充剂后,DHA和相关中间体的新陈代谢在这个年龄组中显示出性别依赖的模式.
研究结果表明,基于性别的个性化n-3PUFA补充策略可能对老年人有益.

关键词:

衰老的衰老衰老的衰老达科萨赫萨埃诺酸是什么意思埃可索帕胺酸是什么意思在更年期后的绝经后.在性爱中,性爱是性爱.

更多相关视频

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...